FDA Inspection
Agilera PharmaAgilera Pharma – FDA Inspection, Dec 1, 2017
Record Details
This FDA Inspection record concerns Agilera Pharma, with an inspection on December 1, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 07ddeb21-8ce2-48cc-a842-3672191eafa9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1035520
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Agilera Pharma
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 24, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 12, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 12, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 19, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Agilera Pharma
- FDA Inspection 1203671 - 2023-03-24
- FDA Inspection 956443 - 2016-01-12
- FDA Inspection 822657 - 2013-03-12
- FDA Inspection 651395 - 2010-02-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.